Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxf1
|
ENSMUSG00000042812.4 | forkhead box F1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_121083687_121083870 | Foxf1 | 608 | 0.358926 | 0.82 | 2.4e-14 | Click! |
chr8_121084168_121084657 | Foxf1 | 26 | 0.791052 | 0.80 | 3.5e-13 | Click! |
chr8_121083930_121084161 | Foxf1 | 341 | 0.598551 | 0.77 | 6.6e-12 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_162037946_162038745 | 22.41 |
2810442N19Rik |
RIKEN cDNA 2810442N19 gene |
33173 |
0.12 |
chr10_111696233_111696479 | 16.19 |
Gm30624 |
predicted gene, 30624 |
28828 |
0.14 |
chr13_81089992_81090512 | 15.79 |
Gm18517 |
predicted gene, 18517 |
2688 |
0.21 |
chr12_79674954_79675872 | 14.52 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr8_19707145_19707732 | 13.96 |
Gm7760 |
predicted gene 7760 |
4267 |
0.18 |
chr9_48723467_48723688 | 13.56 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
112368 |
0.06 |
chr10_9549977_9550305 | 13.03 |
Gm48755 |
predicted gene, 48755 |
2620 |
0.19 |
chr4_108092707_108093041 | 12.61 |
Podn |
podocan |
3571 |
0.17 |
chr5_143992575_143993038 | 12.37 |
Ccz1 |
CCZ1 vacuolar protein trafficking and biogenesis associated |
222 |
0.89 |
chr2_178454797_178455512 | 11.83 |
Cdh26 |
cadherin-like 26 |
5476 |
0.22 |
chr7_80554187_80554617 | 11.66 |
Blm |
Bloom syndrome, RecQ like helicase |
19283 |
0.14 |
chr4_100101880_100102395 | 11.24 |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
6346 |
0.22 |
chr11_43182418_43182702 | 11.08 |
Atp10b |
ATPase, class V, type 10B |
26889 |
0.17 |
chr15_94238011_94238507 | 10.93 |
Adamts20 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 20 |
165999 |
0.04 |
chr11_75051754_75052287 | 10.85 |
Gm12333 |
predicted gene 12333 |
12672 |
0.12 |
chr14_60856601_60856807 | 10.38 |
Mipep |
mitochondrial intermediate peptidase |
72066 |
0.09 |
chr13_32924949_32925251 | 10.01 |
Gm11382 |
predicted pseudogene 11382 |
13591 |
0.13 |
chr8_35987554_35987731 | 9.94 |
Gm22030 |
predicted gene, 22030 |
10064 |
0.21 |
chr10_120914717_120915223 | 9.73 |
Gm16166 |
predicted gene 16166 |
13216 |
0.13 |
chr13_96387644_96388785 | 9.64 |
Poc5 |
POC5 centriolar protein |
80 |
0.97 |
chr5_75544730_75544896 | 9.63 |
Gm24502 |
predicted gene, 24502 |
16337 |
0.2 |
chr7_139412216_139412508 | 9.60 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
11873 |
0.24 |
chr5_115977292_115977636 | 9.34 |
Cit |
citron |
9439 |
0.15 |
chr2_31124792_31124962 | 9.34 |
Fnbp1 |
formin binding protein 1 |
8565 |
0.16 |
chr14_22751323_22751729 | 9.32 |
Gm7473 |
predicted gene 7473 |
23718 |
0.26 |
chr6_93274132_93274418 | 9.20 |
Gm44220 |
predicted gene, 44220 |
32555 |
0.19 |
chr5_76441429_76441712 | 9.18 |
Gm42665 |
predicted gene 42665 |
10204 |
0.16 |
chr8_116252769_116252954 | 9.12 |
4930422C21Rik |
RIKEN cDNA 4930422C21 gene |
65492 |
0.13 |
chr5_123067867_123068018 | 9.09 |
Tmem120b |
transmembrane protein 120B |
473 |
0.61 |
chr1_168012047_168012363 | 8.99 |
Gm20711 |
predicted gene 20711 |
8066 |
0.32 |
chr8_126833325_126834152 | 8.87 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
5495 |
0.23 |
chr4_100101513_100101843 | 8.84 |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
5887 |
0.22 |
chr8_121035643_121035794 | 8.82 |
Fendrr |
Foxf1 adjacent non-coding developmental regulatory RNA |
24695 |
0.13 |
chr7_134177233_134177384 | 8.71 |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
4364 |
0.28 |
chr3_152170492_152170664 | 8.66 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
4348 |
0.14 |
chr11_98721523_98721750 | 8.60 |
Med24 |
mediator complex subunit 24 |
2826 |
0.13 |
chr7_143769581_143769748 | 8.59 |
Mrgprg |
MAS-related GPR, member G |
2671 |
0.15 |
chr2_110294800_110295277 | 8.50 |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
10703 |
0.22 |
chr3_108759919_108760148 | 8.46 |
Aknad1 |
AKNA domain containing 1 |
181 |
0.93 |
chr9_65386559_65386737 | 8.36 |
Kbtbd13 |
kelch repeat and BTB (POZ) domain containing 13 |
5004 |
0.1 |
chr9_96478160_96479055 | 8.25 |
Rnf7 |
ring finger protein 7 |
3 |
0.97 |
chr7_109561915_109562427 | 8.19 |
Denn2b |
DENN domain containing 2B |
21738 |
0.12 |
chr10_39659287_39660442 | 8.17 |
2900078I11Rik |
RIKEN cDNA 2900078I11 gene |
1438 |
0.28 |
chr2_148373587_148373783 | 8.14 |
Sstr4 |
somatostatin receptor 4 |
21659 |
0.17 |
chr7_71440430_71440999 | 8.05 |
Gm29328 |
predicted gene 29328 |
70381 |
0.1 |
chr1_130467320_130467765 | 8.04 |
Gm37109 |
predicted gene, 37109 |
430 |
0.73 |
chr6_131411592_131411743 | 8.00 |
Gm18688 |
predicted gene, 18688 |
22244 |
0.12 |
chr9_119926488_119926652 | 8.00 |
Wdr48 |
WD repeat domain 48 |
5272 |
0.13 |
chr7_134071379_134071541 | 7.97 |
Gm19514 |
predicted gene, 19514 |
28818 |
0.22 |
chr11_94872744_94873468 | 7.95 |
A430060F13Rik |
RIKEN cDNA A430060F13 gene |
11347 |
0.12 |
chr2_78416663_78417010 | 7.91 |
Gm14460 |
predicted gene 14460 |
96500 |
0.08 |
chr9_61370339_61371660 | 7.90 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr10_68090596_68090764 | 7.90 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
45946 |
0.13 |
chr8_34573225_34573456 | 7.85 |
Gm34096 |
predicted gene, 34096 |
34965 |
0.14 |
chr14_63272981_63273156 | 7.84 |
Gata4 |
GATA binding protein 4 |
1376 |
0.41 |
chr5_64840081_64840553 | 7.81 |
Klf3 |
Kruppel-like factor 3 (basic) |
13508 |
0.15 |
chr1_85084738_85085997 | 7.75 |
Gm18342 |
predicted gene, 18342 |
5131 |
0.1 |
chr1_60609474_60609750 | 7.62 |
Gm23762 |
predicted gene, 23762 |
4191 |
0.16 |
chr14_48475621_48476075 | 7.59 |
Tmem260 |
transmembrane protein 260 |
3526 |
0.2 |
chr13_93992771_93993277 | 7.53 |
Gm47216 |
predicted gene, 47216 |
1256 |
0.46 |
chr13_80940010_80940370 | 7.47 |
5430425K12Rik |
RIKEN cDNA 5430425K12 gene |
221 |
0.9 |
chr7_130279428_130279616 | 7.47 |
Fgfr2 |
fibroblast growth factor receptor 2 |
13259 |
0.25 |
chr12_36977295_36977446 | 7.45 |
Gm18026 |
predicted gene, 18026 |
8220 |
0.16 |
chr13_69433523_69433900 | 7.44 |
Gm44375 |
predicted gene, 44375 |
32314 |
0.14 |
chr12_108445055_108445500 | 7.40 |
Gm15636 |
predicted gene 15636 |
4007 |
0.23 |
chr9_61163761_61164250 | 7.39 |
I730028E13Rik |
RIKEN cDNA I730028E13 gene |
25490 |
0.14 |
chr4_102486495_102487042 | 7.35 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
16371 |
0.29 |
chr5_137078101_137078252 | 7.33 |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
5908 |
0.12 |
chr11_75925837_75926169 | 7.30 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
112 |
0.97 |
chr6_34160067_34160249 | 7.24 |
Slc35b4 |
solute carrier family 35, member B4 |
3324 |
0.22 |
chr13_38580315_38580494 | 7.23 |
Gm40922 |
predicted gene, 40922 |
25539 |
0.11 |
chr3_97039722_97039880 | 7.22 |
Gja5 |
gap junction protein, alpha 5 |
7385 |
0.17 |
chr8_20620783_20620977 | 7.21 |
Gm21119 |
predicted gene, 21119 |
5961 |
0.2 |
chr13_43131939_43132171 | 7.19 |
Phactr1 |
phosphatase and actin regulator 1 |
942 |
0.57 |
chr12_73883828_73884266 | 7.18 |
Gm15283 |
predicted gene 15283 |
14435 |
0.16 |
chr11_78567032_78567187 | 7.16 |
Nlk |
nemo like kinase |
1807 |
0.16 |
chr8_120001973_120002124 | 7.12 |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
678 |
0.67 |
chr8_20833861_20834050 | 7.06 |
Gm20946 |
predicted gene, 20946 |
5602 |
0.15 |
chr2_159732525_159732727 | 7.05 |
Gm11445 |
predicted gene 11445 |
45581 |
0.19 |
chr11_25259740_25260072 | 7.04 |
Gm24255 |
predicted gene, 24255 |
21191 |
0.2 |
chr2_102559020_102559198 | 7.04 |
Pamr1 |
peptidase domain containing associated with muscle regeneration 1 |
8960 |
0.27 |
chr8_19735430_19735613 | 7.02 |
4930467E23Rik |
RIKEN cDNA 4930467E23 gene |
5945 |
0.18 |
chr6_55319573_55319959 | 7.00 |
Gm25458 |
predicted gene, 25458 |
10861 |
0.14 |
chr8_70294294_70294487 | 6.99 |
Ddx49 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 |
1347 |
0.25 |
chr7_145025281_145025579 | 6.95 |
Ccnd1 |
cyclin D1 |
85505 |
0.07 |
chr8_77488246_77488460 | 6.94 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
28703 |
0.14 |
chr7_112012674_112012825 | 6.93 |
Usp47 |
ubiquitin specific peptidase 47 |
10755 |
0.26 |
chr4_150007392_150007724 | 6.93 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
1465 |
0.34 |
chrX_129736567_129736718 | 6.93 |
Diaph2 |
diaphanous related formin 2 |
13100 |
0.3 |
chr13_13492365_13492516 | 6.90 |
Gm48682 |
predicted gene, 48682 |
10035 |
0.14 |
chr18_80635983_80636487 | 6.89 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
27260 |
0.15 |
chr18_75377183_75377482 | 6.78 |
Smad7 |
SMAD family member 7 |
2418 |
0.31 |
chr7_134250430_134250597 | 6.77 |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
18327 |
0.18 |
chr9_66338507_66338685 | 6.75 |
Herc1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
11854 |
0.19 |
chr2_155299641_155299792 | 6.75 |
Pigu |
phosphatidylinositol glycan anchor biosynthesis, class U |
1586 |
0.33 |
chr8_115929769_115930140 | 6.75 |
Gm45733 |
predicted gene 45733 |
42117 |
0.21 |
chr8_20040963_20041142 | 6.73 |
Gm20778 |
predicted gene, 20778 |
5944 |
0.19 |
chr5_64576558_64576709 | 6.71 |
Gm42566 |
predicted gene 42566 |
11814 |
0.12 |
chr11_101232085_101232549 | 6.70 |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
5854 |
0.08 |
chr16_20072790_20072941 | 6.69 |
Klhl24 |
kelch-like 24 |
24677 |
0.18 |
chr14_12073815_12074036 | 6.66 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
17235 |
0.23 |
chr1_64087943_64089121 | 6.65 |
Gm13748 |
predicted gene 13748 |
9878 |
0.19 |
chr7_71368532_71368868 | 6.56 |
Gm29328 |
predicted gene 29328 |
133 |
0.96 |
chr12_109402231_109402908 | 6.51 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
50254 |
0.07 |
chr17_27056546_27056697 | 6.49 |
Itpr3 |
inositol 1,4,5-triphosphate receptor 3 |
683 |
0.5 |
chr13_63111579_63111787 | 6.47 |
Aopep |
aminopeptidase O |
4161 |
0.19 |
chr16_14296614_14297032 | 6.47 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
5451 |
0.16 |
chr2_143852696_143852937 | 6.46 |
Rps13-ps6 |
ribosomal protein S13, pseudogene 6 |
2833 |
0.2 |
chr6_108638896_108639047 | 6.46 |
Gm17055 |
predicted gene 17055 |
17946 |
0.14 |
chr8_33889104_33889277 | 6.46 |
Rbpms |
RNA binding protein gene with multiple splicing |
592 |
0.71 |
chr2_150003474_150003817 | 6.45 |
Gm14140 |
predicted gene 14140 |
107931 |
0.06 |
chr6_99520900_99522395 | 6.44 |
Foxp1 |
forkhead box P1 |
485 |
0.83 |
chr9_106318067_106318383 | 6.44 |
Poc1a |
POC1 centriolar protein A |
9503 |
0.13 |
chr5_107046596_107046884 | 6.42 |
Gm33474 |
predicted gene, 33474 |
2096 |
0.34 |
chr18_61652387_61652726 | 6.42 |
Mir143 |
microRNA 143 |
3298 |
0.14 |
chr7_16792307_16792658 | 6.41 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
545 |
0.64 |
chr7_66929303_66929767 | 6.39 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
20067 |
0.18 |
chr9_50192472_50193026 | 6.39 |
Gm8907 |
predicted gene 8907 |
5704 |
0.21 |
chr2_84519488_84520043 | 6.37 |
Gm13710 |
predicted gene 13710 |
11557 |
0.16 |
chr12_9847846_9848083 | 6.35 |
Gm22845 |
predicted gene, 22845 |
17486 |
0.26 |
chr4_138939089_138939246 | 6.33 |
Otud3 |
OTU domain containing 3 |
25222 |
0.12 |
chr11_91065453_91065604 | 6.30 |
4930405D11Rik |
RIKEN cDNA 4930405D11 gene |
182183 |
0.03 |
chr11_63093717_63093868 | 6.30 |
Tekt3 |
tektin 3 |
32138 |
0.15 |
chr18_11268439_11268736 | 6.29 |
Gata6 |
GATA binding protein 6 |
209540 |
0.02 |
chr6_90650730_90650881 | 6.25 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
11483 |
0.14 |
chr18_44442097_44442264 | 6.23 |
Dcp2 |
decapping mRNA 2 |
61653 |
0.11 |
chr8_83521060_83521222 | 6.22 |
Olfr370 |
olfactory receptor 370 |
14639 |
0.1 |
chr8_124572166_124572337 | 6.21 |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
2545 |
0.24 |
chr12_29983291_29983469 | 6.19 |
Pxdn |
peroxidasin |
13058 |
0.25 |
chr11_101953061_101953363 | 6.17 |
4930417O22Rik |
RIKEN cDNA 4930417O22 gene |
791 |
0.44 |
chr7_115501491_115501878 | 6.15 |
Sox6 |
SRY (sex determining region Y)-box 6 |
96212 |
0.09 |
chr8_94354109_94354553 | 6.14 |
Slc12a3 |
solute carrier family 12, member 3 |
715 |
0.52 |
chr13_102624971_102625122 | 6.12 |
Gm47014 |
predicted gene, 47014 |
20513 |
0.2 |
chr13_112172055_112172539 | 6.11 |
Gm48802 |
predicted gene, 48802 |
229 |
0.93 |
chr16_10664965_10665321 | 6.09 |
Gm15558 |
predicted gene 15558 |
18396 |
0.16 |
chr5_118380632_118381262 | 6.08 |
Gm28563 |
predicted gene 28563 |
16383 |
0.19 |
chr9_25499004_25499155 | 6.07 |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
16212 |
0.19 |
chr12_84834884_84835050 | 6.07 |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
35504 |
0.1 |
chr16_10349978_10350197 | 6.04 |
Gm1600 |
predicted gene 1600 |
2496 |
0.24 |
chr15_6278770_6278923 | 6.03 |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
20942 |
0.19 |
chr19_55741662_55741936 | 5.98 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
21 |
0.99 |
chr7_82431698_82431849 | 5.98 |
Adamtsl3 |
ADAMTS-like 3 |
23299 |
0.22 |
chr10_111936919_111937157 | 5.96 |
Krr1 |
KRR1, small subunit (SSU) processome component, homolog (yeast) |
35626 |
0.12 |
chr5_139681780_139682442 | 5.96 |
Gm42424 |
predicted gene 42424 |
19536 |
0.16 |
chr13_44839668_44840451 | 5.89 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
632 |
0.7 |
chr16_86547623_86547774 | 5.88 |
Gm49572 |
predicted gene, 49572 |
211201 |
0.02 |
chr6_103810041_103810781 | 5.88 |
Gm25656 |
predicted gene, 25656 |
22167 |
0.25 |
chr6_98797460_98797650 | 5.87 |
Gm32308 |
predicted gene, 32308 |
39806 |
0.18 |
chr8_126805357_126806196 | 5.87 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
33457 |
0.16 |
chr8_33826859_33827010 | 5.87 |
Gm26632 |
predicted gene, 26632 |
13731 |
0.15 |
chr7_34255173_34255335 | 5.87 |
4931406P16Rik |
RIKEN cDNA 4931406P16 gene |
1965 |
0.17 |
chr5_107188835_107188986 | 5.86 |
Tgfbr3 |
transforming growth factor, beta receptor III |
3457 |
0.21 |
chr19_16448907_16449082 | 5.85 |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
9694 |
0.17 |
chr9_96432543_96432694 | 5.84 |
BC043934 |
cDNA sequence BC043934 |
4816 |
0.17 |
chr3_52938291_52938546 | 5.84 |
Gm20750 |
predicted gene, 20750 |
10752 |
0.18 |
chr1_170064080_170064286 | 5.84 |
Ddr2 |
discoidin domain receptor family, member 2 |
24761 |
0.17 |
chr12_90930434_90930602 | 5.83 |
Gm47688 |
predicted gene, 47688 |
7864 |
0.19 |
chr6_12105247_12105418 | 5.81 |
Gm6578 |
predicted gene 6578 |
4251 |
0.27 |
chr6_82084447_82084610 | 5.76 |
Gm15864 |
predicted gene 15864 |
31947 |
0.15 |
chr7_76651216_76651367 | 5.76 |
2310001K20Rik |
RIKEN cDNA 2310001K20 gene |
40226 |
0.19 |
chr5_134947805_134948001 | 5.76 |
Cldn4 |
claudin 4 |
969 |
0.31 |
chr3_122058882_122059222 | 5.75 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
12476 |
0.17 |
chr12_17318527_17318803 | 5.74 |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
6000 |
0.16 |
chr9_53356660_53357108 | 5.73 |
Exph5 |
exophilin 5 |
15695 |
0.16 |
chr11_76375125_76375306 | 5.72 |
Nxn |
nucleoredoxin |
23853 |
0.16 |
chr18_12109756_12109977 | 5.71 |
Tmem241 |
transmembrane protein 241 |
3555 |
0.22 |
chr3_105000592_105000743 | 5.70 |
Gm40117 |
predicted gene, 40117 |
6635 |
0.17 |
chr5_123413987_123414138 | 5.68 |
Gm43813 |
predicted gene 43813 |
7575 |
0.09 |
chr11_61465472_61465764 | 5.68 |
Rnf112 |
ring finger protein 112 |
11487 |
0.11 |
chr13_30567627_30567784 | 5.66 |
Uqcrfs1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
22343 |
0.2 |
chr2_45747780_45747940 | 5.66 |
Gm13467 |
predicted gene 13467 |
3824 |
0.24 |
chr18_44463521_44463690 | 5.66 |
Mcc |
mutated in colorectal cancers |
55911 |
0.13 |
chr5_91200347_91200638 | 5.64 |
Gm23092 |
predicted gene, 23092 |
17512 |
0.2 |
chr8_41015481_41015652 | 5.62 |
Mtus1 |
mitochondrial tumor suppressor 1 |
754 |
0.56 |
chr6_119052862_119053014 | 5.62 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
27069 |
0.24 |
chr15_27788001_27788934 | 5.62 |
Trio |
triple functional domain (PTPRF interacting) |
171 |
0.96 |
chr3_116301732_116302090 | 5.62 |
Gm29151 |
predicted gene 29151 |
48192 |
0.11 |
chr11_48568078_48568277 | 5.61 |
Gm12180 |
predicted gene 12180 |
178 |
0.95 |
chr14_103899088_103899833 | 5.59 |
Gm37910 |
predicted gene, 37910 |
48636 |
0.15 |
chr17_67351498_67351790 | 5.58 |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
2429 |
0.44 |
chr16_38649508_38649694 | 5.57 |
Gm15530 |
predicted gene 15530 |
36268 |
0.12 |
chr8_88555637_88556171 | 5.57 |
Gm45496 |
predicted gene 45496 |
4129 |
0.24 |
chr15_85232128_85232414 | 5.57 |
Fbln1 |
fibulin 1 |
26266 |
0.17 |
chr11_85893777_85894105 | 5.56 |
Tbx4 |
T-box 4 |
2824 |
0.24 |
chr2_101751249_101751573 | 5.55 |
Prr5l |
proline rich 5 like |
46239 |
0.14 |
chr7_16618662_16618871 | 5.55 |
Gm29442 |
predicted gene 29442 |
1066 |
0.29 |
chr12_45006812_45006963 | 5.54 |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
6077 |
0.24 |
chr7_87227408_87227579 | 5.53 |
Gm6230 |
predicted gene 6230 |
15392 |
0.22 |
chr11_64268274_64268425 | 5.52 |
Gm12290 |
predicted gene 12290 |
103776 |
0.07 |
chr9_111148143_111148294 | 5.50 |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
13085 |
0.17 |
chr5_17924316_17924557 | 5.50 |
Cd36 |
CD36 molecule |
35635 |
0.19 |
chr12_80114135_80114615 | 5.48 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
1362 |
0.27 |
chr1_167951883_167952034 | 5.46 |
Gm20711 |
predicted gene 20711 |
52181 |
0.18 |
chr5_98582037_98582338 | 5.45 |
1700010H22Rik |
RIKEN cDNA 1700010H22 gene |
15183 |
0.19 |
chr9_60373485_60373642 | 5.45 |
Gm47676 |
predicted gene, 47676 |
20194 |
0.18 |
chr3_38128498_38128662 | 5.45 |
Gm43821 |
predicted gene 43821 |
1611 |
0.39 |
chr13_48566607_48566899 | 5.42 |
Gm25232 |
predicted gene, 25232 |
5631 |
0.1 |
chr5_103366088_103366379 | 5.41 |
5430427N15Rik |
RIKEN cDNA 5430427N15 gene |
9535 |
0.16 |
chr2_60940262_60940686 | 5.41 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22718 |
0.21 |
chr2_84850740_84851058 | 5.41 |
Slc43a1 |
solute carrier family 43, member 1 |
10274 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
3.0 | 9.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.1 | 6.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.0 | 6.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.0 | 6.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 7.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.8 | 9.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.8 | 5.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.7 | 5.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.6 | 11.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.6 | 4.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.6 | 4.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.5 | 10.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.5 | 4.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.5 | 10.2 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
1.4 | 4.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.4 | 5.6 | GO:0003284 | septum primum development(GO:0003284) |
1.4 | 4.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.4 | 2.8 | GO:0010159 | specification of organ position(GO:0010159) |
1.3 | 4.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.3 | 3.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.2 | 7.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.2 | 3.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.2 | 4.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.1 | 1.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
1.1 | 5.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.0 | 4.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.0 | 11.4 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 9.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.0 | 3.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.0 | 7.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.0 | 3.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.0 | 3.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.0 | 3.9 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.9 | 3.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.9 | 2.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.9 | 5.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.9 | 3.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.9 | 2.7 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.9 | 2.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.9 | 0.9 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.9 | 2.6 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.9 | 4.3 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.9 | 1.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.8 | 2.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 4.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.8 | 0.8 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.8 | 2.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 3.2 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.8 | 2.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.8 | 2.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 2.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.8 | 3.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.8 | 2.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.8 | 2.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.8 | 2.3 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.8 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 0.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.8 | 6.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.8 | 1.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.8 | 3.0 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.8 | 3.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.8 | 3.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 2.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 3.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.7 | 2.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 3.7 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.7 | 0.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.7 | 4.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.7 | 2.9 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.7 | 2.9 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.7 | 1.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.7 | 4.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 3.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.7 | 4.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.7 | 4.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 1.4 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.7 | 2.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.7 | 2.7 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.7 | 2.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 2.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.7 | 4.6 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 1.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.7 | 2.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.7 | 1.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 3.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.3 | GO:0003166 | bundle of His development(GO:0003166) |
0.6 | 3.9 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.6 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 0.6 | GO:0015819 | lysine transport(GO:0015819) |
0.6 | 3.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.6 | 4.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 | 1.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.6 | 4.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.6 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 3.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 3.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.6 | 1.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 0.6 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.6 | 2.5 | GO:0007494 | midgut development(GO:0007494) |
0.6 | 4.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 3.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.6 | 9.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.6 | 1.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 1.8 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.6 | 1.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.6 | 1.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.6 | 2.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.6 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.6 | 2.4 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.6 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.6 | 1.8 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.6 | 4.7 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 1.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.7 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 1.2 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.6 | 4.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 3.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.6 | 2.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 0.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 1.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.6 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.6 | 0.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) centrosome separation(GO:0051299) |
0.6 | 4.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 2.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 2.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 1.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 1.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 3.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 1.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 1.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.5 | 1.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 4.2 | GO:0060068 | vagina development(GO:0060068) |
0.5 | 1.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 1.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.5 | 1.6 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 0.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.5 | 0.5 | GO:0060157 | urinary bladder development(GO:0060157) |
0.5 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.5 | 1.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 2.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 1.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 6.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 0.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 2.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 1.0 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 1.5 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 5.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 2.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.5 | 2.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.5 | 1.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 1.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 1.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.5 | 1.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.5 | 5.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.5 | 1.9 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.5 | 3.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.5 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 0.5 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.5 | 1.4 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 1.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 1.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.5 | 1.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 2.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 1.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 1.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 1.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 0.9 | GO:0051593 | response to folic acid(GO:0051593) |
0.5 | 0.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 0.5 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.4 | 4.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.4 | 1.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 4.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 3.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 1.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 0.9 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 1.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 3.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 1.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.4 | 0.4 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.4 | 2.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 1.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.4 | 1.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 1.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 6.9 | GO:0009648 | photoperiodism(GO:0009648) |
0.4 | 1.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 0.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.4 | 0.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 0.8 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.4 | 1.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 5.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 0.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 3.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 2.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 4.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.4 | 2.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 1.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 1.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 1.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 1.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 2.0 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.4 | 1.6 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 1.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 0.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 0.4 | GO:0071599 | otic vesicle development(GO:0071599) |
0.4 | 3.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 0.8 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.4 | 1.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 3.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 1.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 2.8 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.4 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.2 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.4 | 1.2 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 2.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 0.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 0.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.4 | 1.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 0.8 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.4 | 1.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 1.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 2.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 0.4 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.4 | 0.8 | GO:0010534 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
0.4 | 1.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 1.5 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 1.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 2.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 1.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 1.1 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 1.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.4 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.4 | 1.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 0.4 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.4 | 0.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 1.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 0.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 0.7 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.4 | 2.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.4 | 1.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.4 | 0.7 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.4 | 6.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 1.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.4 | 0.4 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.4 | 3.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 0.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.4 | 1.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 3.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.4 | 2.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 0.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 1.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 1.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 0.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 3.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 5.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 1.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 1.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.3 | 1.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.3 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.3 | 2.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 1.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 1.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 2.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 10.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.3 | 0.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.3 | 1.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 2.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 1.3 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.3 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 1.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.3 | 1.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 1.0 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 0.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.3 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 2.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 1.3 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 3.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 5.4 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 3.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.3 | 0.9 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.3 | 0.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 0.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 3.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 1.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 1.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 0.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 1.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 1.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 0.3 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 7.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.6 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 1.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 1.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 3.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 3.6 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.3 | 0.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 1.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 1.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 0.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 0.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.6 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 0.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.6 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.3 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.9 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.3 | 3.2 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.3 | 1.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.3 | 1.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 1.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.3 | 0.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.6 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 1.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 1.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 0.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 1.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.3 | 1.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.3 | 4.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 1.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 3.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.3 | 7.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.3 | 1.9 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.3 | 2.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.3 | 0.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 2.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 3.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 1.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 2.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 0.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 0.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.8 | GO:0031100 | organ regeneration(GO:0031100) |
0.3 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.8 | GO:1904746 | negative regulation of apoptotic process involved in development(GO:1904746) |
0.3 | 0.3 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.3 | 1.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 2.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 1.1 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.3 | 1.3 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 1.0 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.3 | 0.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 0.5 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.3 | 4.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 1.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.3 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
0.3 | 0.8 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.8 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 0.5 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 0.3 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 0.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 1.3 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.3 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.3 | GO:0035789 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) regulation of metanephric mesenchymal cell migration(GO:2000589) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.5 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 1.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 1.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 3.7 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 1.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.2 | 1.2 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 3.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 0.2 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 1.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 1.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.5 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 1.5 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.2 | 2.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 3.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 1.4 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.2 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 1.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.5 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.2 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 2.8 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 1.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 1.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 9.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 2.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 1.6 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 1.8 | GO:0097369 | sodium ion import(GO:0097369) |
0.2 | 3.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 2.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.7 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 1.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.2 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.2 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 2.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.9 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 0.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 0.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.7 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.2 | 0.7 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 1.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 0.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 3.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.4 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.3 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 5.0 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 2.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 1.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 3.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 2.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 2.5 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 4.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 1.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 0.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 1.6 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.2 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 1.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 3.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.4 | GO:0014732 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.2 | 1.0 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.2 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.2 | 1.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.2 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.8 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 2.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 2.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 1.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.8 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 0.8 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.2 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.2 | 0.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 2.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 1.5 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.6 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 2.6 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.2 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.2 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 1.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.9 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 1.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 0.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.2 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.7 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 6.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 1.0 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.7 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 0.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 1.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.7 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.2 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 1.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 2.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 0.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 1.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 2.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.5 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.7 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 1.2 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.2 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 1.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 4.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.3 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.2 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.3 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.2 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 2.4 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.6 | GO:0070206 | protein trimerization(GO:0070206) |
0.2 | 0.3 | GO:0090160 | regulation of natural killer cell degranulation(GO:0043321) Golgi to lysosome transport(GO:0090160) |
0.2 | 0.2 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.2 | 0.8 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 1.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 1.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 1.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 2.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.8 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.2 | 0.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.6 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 2.8 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.1 | 0.7 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.1 | 0.4 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 2.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 1.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 1.6 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 4.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.3 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.4 | GO:0019083 | viral transcription(GO:0019083) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.7 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 1.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.1 | 0.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.3 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.3 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 1.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 3.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.1 | 2.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 3.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 1.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:1903659 | negative regulation of NAD(P)H oxidase activity(GO:0033861) complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 1.7 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.9 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.6 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 1.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.6 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.6 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 1.4 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 0.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 0.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.1 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.1 | 0.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.5 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.1 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.1 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.1 | 0.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 2.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 1.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 2.2 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 2.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.8 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.9 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.3 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 5.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 1.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.6 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.4 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.4 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.5 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0060631 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.1 | 5.9 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.1 | 0.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 2.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 1.7 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.3 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.5 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.7 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.6 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.3 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0042511 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.9 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 1.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.9 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 1.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 2.4 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.1 | 1.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 0.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 2.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.2 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 1.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.8 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.2 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 1.3 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 1.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.4 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 3.3 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.1 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.6 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 4.7 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.6 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 1.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.1 | 0.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 1.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 2.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.1 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.1 | 4.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.5 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0033686 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 3.3 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.4 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.2 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.1 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.2 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.3 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.1 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.2 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.1 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.2 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.1 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.1 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.4 | GO:0019080 | viral gene expression(GO:0019080) |
0.0 | 0.1 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.3 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.6 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.0 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.1 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 1.4 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.1 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.0 | 0.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
0.0 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.0 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.0 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.4 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 1.2 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.5 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.0 | 0.2 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.1 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.4 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.0 | 0.0 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0009415 | response to water(GO:0009415) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:0002287 | alpha-beta T cell activation involved in immune response(GO:0002287) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:1905153 | regulation of membrane invagination(GO:1905153) |
0.0 | 0.4 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0018202 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.0 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.0 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.0 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.8 | 7.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.6 | 4.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 4.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.3 | 3.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.2 | 4.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.1 | 3.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.1 | 5.5 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 3.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.0 | 2.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.8 | 2.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.8 | 2.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 3.2 | GO:0035363 | histone locus body(GO:0035363) |
0.8 | 3.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 2.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 5.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.7 | 2.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.6 | 3.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 3.8 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 1.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 3.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 9.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 2.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 1.6 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 3.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 8.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 2.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 31.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 4.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 16.4 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 1.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 1.5 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 2.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 2.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 1.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 3.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 1.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 1.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 3.5 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.3 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 4.1 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 3.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 1.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 2.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 4.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.4 | 1.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 6.1 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 1.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 1.9 | GO:0033503 | HULC complex(GO:0033503) |
0.4 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 1.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 4.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 1.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 4.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 2.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 1.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 1.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 4.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 3.0 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 4.2 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 2.5 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 6.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 0.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 9.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 2.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 1.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 1.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 0.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 2.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 1.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 6.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 7.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 2.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 3.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 0.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 1.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 3.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 15.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.7 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 1.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 1.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.7 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 2.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 3.2 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 2.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 4.4 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 2.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 2.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 3.1 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 3.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 11.3 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 2.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 48.4 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.2 | 0.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 2.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 1.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.3 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 4.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.2 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.2 | 1.0 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 3.9 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 9.5 | GO:0005901 | caveola(GO:0005901) |
0.2 | 2.4 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.2 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 3.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.6 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 9.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 1.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 3.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 23.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 6.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 5.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 3.6 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 6.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.7 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 1.4 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 1.3 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.5 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 4.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 1.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 5.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 4.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 6.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 1.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 8.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 7.1 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 8.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 16.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 3.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 3.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 3.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 9.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.3 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.2 | GO:0044448 | cell cortex part(GO:0044448) |
0.1 | 1.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 3.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 11.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 14.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 5.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 13.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 2.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 2.0 | GO:0044450 | microtubule organizing center part(GO:0044450) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.5 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 3.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 1.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) symmetric synapse(GO:0032280) |
0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 1.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.7 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.5 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 11.6 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.0 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.8 | 5.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.7 | 7.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.7 | 5.2 | GO:0070538 | oleic acid binding(GO:0070538) |
1.4 | 5.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.3 | 7.5 | GO:0030274 | LIM domain binding(GO:0030274) |
1.1 | 3.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 3.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.1 | 4.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.1 | 3.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.1 | 3.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 3.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.0 | 7.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.0 | 3.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.0 | 5.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 7.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.0 | 2.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.0 | 3.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.0 | 2.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 7.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.9 | 5.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 3.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 2.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 3.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.8 | 3.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 5.2 | GO:0018653 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.7 | 2.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 3.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 7.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 2.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 2.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 2.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.7 | 2.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 2.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 2.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 3.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.7 | 2.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 2.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.7 | 2.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.7 | 2.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 1.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 1.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 2.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 7.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 1.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.6 | 8.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 1.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 1.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 3.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.6 | 3.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 2.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 2.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 6.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 0.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.6 | 2.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 1.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.5 | 2.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 4.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 2.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 2.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 4.1 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 4.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.5 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 9.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 1.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 2.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 4.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 1.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.5 | 0.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 3.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.5 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 2.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 2.2 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 1.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 1.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 6.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 3.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 4.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 1.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.4 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 0.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 0.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 1.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 3.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 1.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 1.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 1.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 3.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 1.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 3.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 2.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 19.7 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 1.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 5.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 4.2 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 2.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 1.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 1.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 0.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.4 | 2.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 3.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 2.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.8 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.4 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.3 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.3 | 5.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 7.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 2.0 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 8.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.3 | 1.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 3.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 1.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 0.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 1.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 5.8 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 2.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 5.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 2.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 2.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 4.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 2.5 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 2.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 1.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 1.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 1.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 0.3 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.3 | 8.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.3 | 6.3 | GO:0008875 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.3 | 1.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 10.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 2.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 2.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 2.8 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.3 | 0.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 23.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 6.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 2.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 12.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 1.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 2.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 1.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 2.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 4.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 2.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 2.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.4 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 3.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 14.0 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 1.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 2.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 3.0 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 1.5 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 2.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 2.9 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 1.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 2.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 2.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 7.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 3.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 12.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 0.2 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 0.8 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 6.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 0.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 14.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 3.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 2.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 3.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 2.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 2.6 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 3.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 1.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 2.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 4.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 2.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 44.0 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 2.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 4.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 1.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.4 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 3.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 12.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 9.5 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 3.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.4 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 1.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 2.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 1.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 2.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0034934 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.1 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 2.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 0.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 1.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 2.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 11.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.7 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.5 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 5.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 9.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.3 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 1.8 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 2.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0034559 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 1.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 1.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 1.6 | GO:0019111 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 2.2 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.0 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 1.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 2.7 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.0 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.1 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.7 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 3.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 3.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.5 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.0 | 0.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 0.1 | GO:0034821 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 16.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 1.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 7.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 5.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 22.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 9.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 1.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 1.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 14.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 9.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 8.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 2.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 4.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 2.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 2.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 20.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 3.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 2.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 3.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 3.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 2.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 11.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 5.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 5.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 11.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 3.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 3.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 2.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 5.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 1.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 5.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 2.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 3.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 7.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 4.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 3.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 7.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 6.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 5.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 3.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 2.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 4.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 4.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 3.6 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 4.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 1.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 2.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 6.8 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 3.5 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 4.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 4.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 14.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 5.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 2.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 4.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 12.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 2.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 5.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.4 | PID PLK1 PATHWAY | PLK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.9 | 12.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 0.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.6 | 5.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 5.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.5 | 15.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 12.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 5.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 10.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.4 | 3.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 5.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 3.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 5.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 4.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 2.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 6.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 4.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 4.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 3.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 3.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 1.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 1.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 3.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 3.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 5.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 10.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 1.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 2.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 5.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 4.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 4.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 7.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 11.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 2.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 2.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 4.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 2.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 4.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 3.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 1.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 12.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 1.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 4.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 1.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 7.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 1.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 4.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 4.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 1.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 4.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 18.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 4.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 1.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 2.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 5.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 2.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 0.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 3.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 5.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 1.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 4.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 4.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 7.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 5.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 3.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 2.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 6.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 4.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 3.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 14.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.1 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 2.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 9.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 3.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 2.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 6.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 3.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 1.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 4.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.2 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 2.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 4.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 2.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.9 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 2.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |